UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

The Pediatric infectious disease journal, 2020-08, Vol.39 (8), p.763

2020

Volltextzugriff (PDF)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Human vaccines & immunotherapeutics, 2019-03, Vol.15 (3), p.530-539

2019

Volltextzugriff (PDF)

Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISA

Bioanalysis, 2020-10, Vol.12 (19), p.1363-1375

2020

Volltextzugriff (PDF)

Optimization and validation of a microcolony multiplexed opsonophagocytic killing assay for 15 pneumococcal serotypes

Bioanalysis, 2020-07, Vol.12 (14), p.1003-1020

2020

Volltextzugriff (PDF)

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

mSphere, 2023-04, Vol.8 (2), p.e0096221-e0096221

2023

Volltextzugriff (PDF)

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.1-14

2022

Volltextzugriff (PDF)

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine

mSphere, 2022-08, Vol.7 (4), p.e0011422-e0011422

2022

Volltextzugriff (PDF)

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies

PLoS pathogens, 2007-08, Vol.3 (8), p.e117-e117

2007

Volltextzugriff (PDF)

Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors

Journal of Virology, 2008-01, Vol.82 (2), p.664-673

2008

Volltextzugriff (PDF)

Characterization of a Human Immunodeficiency Virus Type 1 V3 Deletion Mutation That Confers Resistance to CCR5 Inhibitors and the Ability To Use Aplaviroc-Bound Receptor

Journal of Virology, 2009-04, Vol.83 (8), p.3798-3809

2009

Volltextzugriff (PDF)

Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys

Vaccine, 2007-10, Vol.25 (42), p.7470-7479

2007

Volltextzugriff (PDF)

Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists

Journal of Virology, 2007-09, Vol.81 (18), p.9956-9966

2007

Volltextzugriff (PDF)

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

Journal for nurses in professional development, 2020-09, Vol.36 (5), p.294

2020

Volltextzugriff (PDF)

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

JAC-antimicrobial resistance, 2023-01, Vol.5 (Supplement_1)

2023

Volltextzugriff (PDF)

2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness

Bioanalysis, 2022-06, Vol.14 (11), p.737-793

2022

Volltextzugriff (PDF)

2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard

Bioanalysis, 2024-04, Vol.16 (7), p.77-119

2024

Volltextzugriff (PDF)

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S572-S572

2018

Volltextzugriff (PDF)

Live attenuatedListeria monocytogenesexpressing HIV Gag: Immunogenicity in rhesus monkeys

Vaccine, 2007-10, Vol.25 (42), p.7470

2007

Volltextzugriff (PDF)

The role of the HIV-1 V3 loop in determining coreceptor tropism and modulating sensitivity to coreceptor inhibitors

Nolan, Katrina M

2008

Volltextzugriff (PDF)

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Human Vaccines & Immunotherapeutics, 2023, Vol.19 (2)

2023

Volltextzugriff (PDF)

Post-stroke lateropulsion and rehabilitation outcomes: a retrospective analysis

Disability and rehabilitation, 2022-09, Vol.44 (18), p.5162-5170

2022

Volltextzugriff (PDF)

Kinetics of the Cellular and Transcriptomic Response to Eimeria maxima in Relatively Resistant and Susceptible Chicken Lines

Frontiers in immunology, 2021-03, Vol.12, p.653085-653085

2021

Volltextzugriff (PDF)

Cyclization of 4‑Phenoxy-2-coumarins and 2‑Pyrones via a Double C–H Activation

Organic letters, 2016-06, Vol.18 (11), p.2540-2543

2016

Volltextzugriff (PDF)

Current trends in rapid tests for mycotoxins

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2019-05, Vol.36 (5), p.800-814

2019

Volltextzugriff (PDF)

Accuracy of the Australian National Sub-Acute and Non-Acute Patient Classification in predicting rehabilitation length of stay for stroke survivors who are ≥65 years of age and have lateropulsion

Topics in stroke rehabilitation, 2023-03, Vol.30 (2), p.203-211

2023

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(64)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISA

Optimization and validation of a microcolony multiplexed opsonophagocytic killing assay for 15 pneumococcal serotypes

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies

Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors

Characterization of a Human Immunodeficiency Virus Type 1 V3 Deletion Mutation That Confers Resistance to CCR5 Inhibitors and the Ability To Use Aplaviroc-Bound Receptor

Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys

Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness

2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

Live attenuatedListeria monocytogenesexpressing HIV Gag: Immunogenicity in rhesus monkeys

The role of the HIV-1 V3 loop in determining coreceptor tropism and modulating sensitivity to coreceptor inhibitors

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Post-stroke lateropulsion and rehabilitation outcomes: a retrospective analysis

Kinetics of the Cellular and Transcriptomic Response to Eimeria maxima in Relatively Resistant and Susceptible Chicken Lines

Cyclization of 4‑Phenoxy-2-coumarins and 2‑Pyrones via a Double C–H Activation

Current trends in rapid tests for mycotoxins

Accuracy of the Australian National Sub-Acute and Non-Acute Patient Classification in predicting rehabilitation length of stay for stroke survivors who are ≥65 years of age and have lateropulsion

Aktive Filter

Suchergebnisse filtern